What are Exagen Inc.'s total assets?

Exagen Inc. (XGN) holds $52.0M in total assets, up 28.9% year over year.

How much debt does Exagen Inc. have?

Exagen Inc. carries $27.1M in total debt against $14.4M of shareholders' equity, a debt-to-equity ratio of 1.88.

How much cash does Exagen Inc. have?

Exagen Inc. holds $21.7M in cash and equivalents.

Can Exagen Inc. cover its short-term obligations?

Its current ratio is 3.47 — current assets exceed current liabilities.

Where does Exagen Inc.'s balance sheet data come from?

Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Exagen Inc. XGN Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$21.71M+90.6%	$32.42M+45.8%	$35.85M+61.2%	$30.23M+22.5%	$11.39M-58.5%
Restricted cash	$200K0.0%	$200K0.0%	$200K0.0%	$200K0.0%	$200K0.0%
Accounts receivable, net	$15.77M+7.1%	$10.86M+38.5%	$11.09M+18.2%	$14.27M+22.0%	$14.73M+35.1%
Prepaid expenses and other current assets	$6.3M-4.3%	$5.82M-11.6%	$5.85M+41.4%	$6.68M+44.9%	$6.58M+55.6%
Total current assets	$43.58M+34.1%	$48.89M+34.1%	$52.59M+47.9%	$50.99M+25.0%	$32.51M-23.3%
Property and equipment, net	$6.61M+31.6%	$6.94M+31.3%	$7.49M+54.4%	$4.58M-11.0%	$5.03M+5.2%
Accumulated depreciation	$7.73M+26.8%	$7.14M+18.8%	$6.76M+20.7%	$6.36M+14.3%	$6.1M+7.6%
Total property and equipment, gross	$14.35M+29.0%	$14.08M+24.7%	$14.25M+36.3%	$10.95M+2.2%	$11.12M+6.5%
Operating lease right-of-use assets	$3.7M+208%	$3.7M+4,624,999,900%	$3.5M+33.1%	$700K-75.5%	$1.2M-60.9%
Intangible assets, net	——	$193K-30.1%	——	——	——
Other non-current assets	$584K-2.0%	$756K+37.5%	$1.06M+87.4%	$1.26M+146%	$596K+6.2%
Allowance for credit losses	$0—	$0—	$0—	$500K—	$0—
Total assets	$51.96M+28.9%	$58.02M+29.8%	$62.82M+44.1%	$58.76M+19.2%	$40.29M-20.7%
Accounts payable	$4.16M-7.8%	$4.15M+0.4%	$3.56M+222%	$2.51M+7.7%	$4.51M+207%
Accrued expenses	$4.77M-3.6%	$6.33M-8.5%	$5.68M-8.0%	$4.94M-12.7%	$4.95M-18.1%
Accrued compensation	$3.66M+6.6%	$5.41M+7.2%	$4.91M+11.2%	$3.46M-8.5%	$3.43M-7.5%
Deferred revenue	$681K-22.3%	$675K-7.9%	$641K—	$1.02M—	$876K—
Current portion of long-term debt	$580K-77.1%	$643K+52.0%	$680K+58.1%	$667K+57.7%	$2.54M+846%
Operating lease liabilities, current	$1.26M+11.7%	$1.23M+11.9%	$1.19M+11.9%	$1.16M+12.1%	$1.13M+12.1%
Finance Lease Liability, Current	$1.11M—	$1.14M+465%	$1.13M+301%	——	——
Contract liabilities	$700K-22.2%	$700K0.0%	$600K—	$1M—	$900K—
Total current liabilities	$12.56M-10.2%	$14.16M+4.8%	$12.89M+46.9%	$10.3M+9.0%	$14M+59.3%
Deferred tax liabilities	——	$1.18M+66.7%	——	——	——
Long-term debt	$22.29M+21.1%	$22.26M+12.3%	$22.26M+12.3%	$22.31M+12.5%	$18.41M-4.5%
Operating lease liabilities, non-current	$111K-91.9%	$438K-73.7%	$759K-61.1%	$1.07M-52.1%	$1.37M-45.2%
Finance lease liabilities	$1.79M—	$1.96M+1,148%	$2.14M—	——	——
Reserve for insurance claims	——	$917K-4.0%	——	——	——
Total liabilities	$37.53M+10.7%	$40.57M+15.4%	$44.69M+45.4%	$37.73M+18.9%	$33.89M+10.0%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	200M0.0%	200M0.0%	200M0.0%	200M0.0%	200M0.0%
Additional paid-in capital	$332.66M+9.3%	$331.71M+9.2%	$327.72M+8.0%	$323.53M+6.7%	$304.47M+0.6%
Retained earnings	-$318.25M-6.8%	-$314.28M-6.8%	-$309.61M-6.6%	-$302.52M-5.9%	-$298.08M-5.5%
Total stockholders' equity	$14.43M+125%	$17.45M+82.9%	$18.14M+41.0%	$21.03M+19.6%	$6.4M-68.0%
Total liabilities and stockholders' equity	$51.96M+28.9%	$58.02M+29.8%	$62.82M+44.1%	$58.76M+19.2%	$40.29M-20.7%
Other current assets	$4.1M-13.7%	$3.3M-42.4%	$3.53M+20.1%	$3.74M+30.3%	$4.75M+126%
Prepaid expenses and other	$6.3M-4.3%	$5.82M-11.6%	$5.85M+41.4%	$6.68M+44.9%	$6.58M+55.6%
Deferred Tax Assets and Other Non-Current Assets	$584K-2.0%	$3.57M+28.3%	$1.06M+87.4%	$1.26M+146%	$596K+6.2%
Net Investment in Lease	$1.18M-45.6%	$1.44M-40.2%	$1.69M-35.9%	$1.93M-32.4%	$2.17M-29.4%
Operating lease right-of-use assets	$1.18M-45.6%	$1.44M-40.2%	$1.69M-35.9%	$1.93M-32.4%	$2.17M-29.4%
Other non-current assets	$584K-2.0%	$756K+37.5%	$1.06M+87.4%	$1.26M+146%	$596K+6.2%
Property, plant and equipment, net	$6.61M+31.6%	$6.94M+31.3%	$7.49M+54.4%	$4.58M-11.0%	$5.03M+5.2%
Operating Lease Right-of-Use Assets in Other Assets	$1.18M-45.6%	$1.44M-40.2%	$1.69M-35.9%	$1.93M-32.4%	$2.17M-29.4%
Software and Technology Licenses, Net	$584K-2.0%	$756K+37.5%	$1.06M+87.4%	$1.26M+146%	$596K+6.2%
Tax Credit Carryforward Valuation Allowance	——	$49.21M+8.8%	——	——	——
Other Commercial Liabilities	$4.77M-3.6%	$6.33M-8.5%	$5.68M-8.0%	$4.94M-12.7%	$4.95M-18.1%
Accrued Liabilities, Current	$4.77M-3.6%	$6.33M-8.5%	$5.68M-8.0%	$4.94M-12.7%	$4.95M-18.1%
Lease Liability Payments - Due Year Five	——	$30K—	——	——	——
Debt Maturity - 2024	$2.78M+54.2%	——	$944K+82.6%	$1.89M+73.7%	$1.8M+22.8%
Debt Maturity - 2025	$3M—	$6M—	$6M—	——	——
Debt Maturity - 2027	$6M+6,718%	$6M+2,691%	$6M+2,691%	$3.12M+1,350%	$88K-99.6%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$3.17M+5,187%	$3.3M+4,617%	$3.43M+4,193%	$3.56M+3,728%	$60K-41.7%
Operating Lease Liability Payments - 2026 (Lessee)	——	$0-100%	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	$0—	——	——	——
Total debt	$27.15M+15.8%	$27.67M+18.4%	$27.79M+18.0%	$25.2M+5.6%	$23.44M-0.2%
Unrecognized Tax Benefits	——	$0—	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	24.1M+34.2%	22.9M+29.9%	22.5M+28.5%	22M+26.6%	18M+3.6%
Common Stock Shares Outstanding	$186K-34.0%	$957K+159%	$2.58M—	$1.22M—	$282K—
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$24K+33.3%	$23K+27.8%	$23K+27.8%	$22K+29.4%	$18K+5.9%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Number of Exercisable Options	$179K-30.1%	$617K+85.8%	$1.4M+367%	$741K—	$256K—
Number of Vested and Expected to Vest Options	$186K-34.0%	$957K+159%	$2.58M—	$1.22M—	$282K—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	706.8K+16.2%	526.8K+7.7%	526.9K—	564.4K—	608.1K—
Share Price	——	$6.08+48.3%	——	——	——
Shares Reserved for Future Issuance Under Stock Plans	——	6M-1.4%	——	——	——
Warrants and Rights Outstanding	131-100.0%	819.4K-27.5%	1.4M+22.6%	1.4M+14.1%	1.1M-6.9%
Weighted Average Exercise Price of Exercisable Options	$7.68-10.7%	$8.07-6.7%	$8.11—	$8.54—	$8.60—
Weighted Average Exercise Price of Outstanding Options	$5.91-20.4%	$6.86-18.2%	$6.86—	$7.21—	$7.42—
Weighted Average Exercise Price of Vested and Expected to Vest Options	$5.91-20.4%	$6.86-18.2%	$6.86—	$7.21—	$7.42—
Class of Warrant or Right, Outstanding	$131-100.0%	$819.36K-27.5%	$1.39M+22.6%	$1.39M+14.1%	$1.13M-6.9%
Common stock, capital shares reserved for future issuance	——	$5.96M-1.4%	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$24.09M+34.2%	$22.91M+29.9%	$22.51M+28.5%	$22M+26.6%	$17.95M+3.6%
Common Stock, Shares, Outstanding	$24.09M+34.2%	$22.91M+29.9%	$22.51M+28.5%	$22M+26.6%	$17.95M+3.6%
Contract with Customer, Liability	$700K-22.2%	$700K0.0%	$600K—	$1M—	$900K—
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$3.17M+5,187%	$3.3M+4,617%	$3.43M+4,193%	$3.56M+3,728%	$60K-41.7%
Deferred Tax Liabilities, Gross	——	$1.18M+66.7%	——	——	——
Deferred Tax Assets, Goodwill and Intangible Assets	——	$193K-30.1%	——	——	——
Deferred Tax Assets, Gross	——	$50.39M+9.7%	——	——	——
Lease liability	——	$1.08M+59.2%	——	——	——
Deferred Tax Assets, Net	——	$0—	——	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	$1.18M+66.7%	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards	——	$39.78M+12.5%	——	——	——
R&D credit carryforward	——	$2.36M0.0%	——	——	——
Capitalization of research and experimentation costs	——	$1.89M-35.6%	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	$596K-0.3%	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves	——	$917K-4.0%	——	——	——
Deferred Tax Assets, Valuation Allowance	——	$49.21M+8.8%	——	——	——
Deferred Tax Liabilities, Fixed Assets And Intangible Assets	——	$141K+21.6%	——	——	——
Deferred Tax Liabilities, Right Of Use Assets	——	$1.04M+75.5%	——	——	——
Fair value of finance lease asset	$3.1M—	$3.1M—	$3.1M—	——	——
Current maturities of long-term debt	$1.11M—	$1.14M+465%	$1.13M+301%	——	——
Finance Lease Liability Payments Due Year Five	——	$30K—	——	——	——
Property, plant and equipment	$3.7M+208%	$3.7M+85.0%	$3.5M—	$700K—	$1.2M—
Loan commitment fees	$685K—	$1.18M—	$1.16M—	$1.13M—	——
Long-term Debt, Including Undiscounted Interest	$38.25M+59.3%	$39.18M+64.9%	$40.12M+65.1%	$41.06M+64.0%	$24.02M-2.7%
2028	$3.12M+560%	$3.45M-83.9%	$3.45M-83.9%	$3.45M-83.9%	$472K-97.8%
2029	$2.98M+3,284%	$3.12M+1,350%	$3.12M+1,350%	$3.12M+1,350%	$88K—
2030	$25.93M—	$2.98M+4,345%	$2.98M+4,345%	$2.98M+4,345%	——
2027	$3.45M-84.1%	$3.7M+78.2%	$3.7M+76.4%	$3.7M+68.9%	$21.66M+997%
Remainder of 2026	$2.78M+54.2%	——	$944K+82.6%	$1.89M+73.7%	$1.8M+22.8%
Long-term Debt, Undiscounted Interest Amount	$12.21M+305%	$12.97M+277%	$13.74M+247%	$14.53M+209%	$3.02M-40.2%
Other accrued liabilities	$1.11M-26.5%	$916K-51.0%	$777K+16.3%	$1.49M+305%	$1.52M+158%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Prepaid maintenance and insurance contracts	$1.48M-11.1%	$1.3M+57.1%	$1.12M-4.2%	$1.71M+0.1%	$1.66M-20.1%
Purchase Obligation	$24M—	$24M—	$24M—	——	——
Purchase obligation, 2025	——	$3M—	——	——	——
Purchase obligation, paid in 2025	$3M—	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$5.91-20.4%	$6.86-18.2%	$6.86—	$7.21—	$7.42—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$706.84K+16.2%	$526.84K+7.7%	$526.89K—	$564.44K—	$608.15K—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	$706.84K+16.2%	$526.84K+7.7%	$526.89K—	$564.44K—	$608.15K—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$186K-34.0%	$957K+159%	$2.58M—	$1.22M—	$282K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$5.91-20.4%	$6.86-18.2%	$6.86—	$7.21—	$7.42—
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	$179K-30.1%	$617K+85.8%	$1.4M—	$741K—	$256K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$186K-34.0%	$957K+159%	$2.58M—	$1.22M—	$282K—
Share price (in dollars per share)	——	$6.08+48.3%	——	——	——
Unrecognized tax benefits	——	$0—	——	——	——
Warrant liability	$767K—	$1.75M—	——	——	——
Warrant liability	$767K—	$1.75M—	$6.63M—	$3.96M—	——
Purchase Commitments - Due Next Year	$6M-42.3%	——	$3M-64.3%	$10.4M—	$10.4M—
Purchase Obligation	$24M—	$24M—	$24M—	——	——
Remainder of Fiscal Year 2024	$2.78M+54.2%	——	$944K+82.6%	$1.89M+73.7%	$1.8M+22.8%
Unrecorded Unconditional Purchase Obligation	$6M—	$6M-42.3%	$6M-42.3%	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Exagen Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Exagen Inc.'s total assets?: Exagen Inc. (XGN) holds $52.0M in total assets, up 28.9% year over year.
How much debt does Exagen Inc. have?: Exagen Inc. carries $27.1M in total debt against $14.4M of shareholders' equity, a debt-to-equity ratio of 1.88.
How much cash does Exagen Inc. have?: Exagen Inc. holds $21.7M in cash and equivalents.
Can Exagen Inc. cover its short-term obligations?: Its current ratio is 3.47 — current assets exceed current liabilities.
Where does Exagen Inc.'s balance sheet data come from?: Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.